VARDENAFIL HYDROCHLORIDE

VARDENAFIL HYDROCHLORIDE was reported 82 times

These side effects are most commonly reported by patients taking VARDENAFIL HYDROCHLORIDE:

# Side effect Count
0 ENTEROCOLITIS INFECTIOUS 13
1 OVERDOSE 6
2 VISUAL IMPAIRMENT 6
3 BLOOD PRESSURE INCREASED 5
4 DYSCHROMATOPSIA 5
5 HYPOTENSION 5
6 PHOTOPHOBIA 5
7 RETINAL DEPOSITS 5
8 DIZZINESS 4
9 ERECTILE DYSFUNCTION 4
10 FLUSHING 4
11 INTENTIONAL OVERDOSE 4
12 INTENTIONAL PRODUCT MISUSE 4
13 INTENTIONAL PRODUCT USE ISSUE 4
14 MALAISE 4
15 BRADYCARDIA 3
16 CHRONIC KIDNEY DISEASE 3
17 COUGH 3
18 DRUG INEFFECTIVE 3
19 DYSPHONIA 3
20 DYSPNOEA 3
21 EPILEPSY 3
22 FATIGUE 3
23 GASTROOESOPHAGEAL REFLUX DISEASE 3
24 HYPERSENSITIVITY 3
25 ILLNESS 3
26 INJECTION SITE EXTRAVASATION 3
27 NAUSEA 3
28 OFF LABEL USE 3
29 PULMONARY FUNCTION TEST ABNORMAL 3
30 VISION BLURRED 3
31 VOMITING 3
32 WEIGHT DECREASED 3
33 ABDOMINAL PAIN 2
34 AGITATION 2
35 ANGIOEDEMA 2
36 ARRHYTHMIA 2
37 CELLULITIS 2
38 DIARRHOEA 2
39 DRUG-INDUCED LIVER INJURY 2
40 FALL 2
41 GLOSSODYNIA 2
42 HYPERTENSION 2
43 INSOMNIA 2
44 LOSS OF CONSCIOUSNESS 2
45 MACULAR THICKENING 2
46 NOCTURIA 2
47 OBSTRUCTIVE AIRWAYS DISORDER 2
48 OROPHARYNGEAL PAIN 2
49 PAIN 2
50 PRURITUS 2
51 RENAL FAILURE 2
52 RETINAL DISORDER 2
53 SLEEP APNOEA SYNDROME 2
54 SLEEP DISORDER 2
55 SOMNOLENCE 2
56 SWOLLEN TONGUE 2
57 TONGUE DISCOMFORT 2
58 ABDOMINAL DISCOMFORT 1
59 ACCESSORY SPLEEN 1
60 ADENOIDAL DISORDER 1
61 ADHESIVE TAPE USE 1
62 ADVERSE DRUG REACTION 1
63 ADVERSE EVENT 1
64 ALOPECIA 1
65 ANAEMIA 1
66 ANGINA PECTORIS 1
67 ANHEDONIA 1
68 ANXIETY 1
69 AORTIC ARTERIOSCLEROSIS 1
70 ARTHROPATHY 1
71 ATELECTASIS 1
72 BACK PAIN 1
73 BANKRUPTCY 1
74 BLINDNESS UNILATERAL 1
75 BLOOD PRESSURE DECREASED 1
76 BLOOD PRESSURE DIASTOLIC ABNORMAL 1
77 BLOOD TRIGLYCERIDES INCREASED 1
78 BONE LESION 1
79 BONE PAIN 1
80 BRONCHITIS 1
81 CANCER PAIN 1
82 CARDIOMYOPATHY 1
83 CENTRAL OBESITY 1
84 CEREBRAL HAEMORRHAGE 1
85 CEREBRAL VENOUS THROMBOSIS 1
86 CEREBROVASCULAR ACCIDENT 1
87 CHEST DISCOMFORT 1
88 CHILLS 1
89 CHOLELITHIASIS 1
90 CHOLESTASIS 1
91 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1
92 CIRCULATORY COLLAPSE 1
93 CONDITION AGGRAVATED 1
94 CORONARY ARTERY DISEASE 1
95 DEATH 1
96 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1
97 DEVICE ISSUE 1
98 DIABETES MELLITUS 1
99 DIASTOLIC DYSFUNCTION 1
100 DISABILITY 1
101 DISTURBANCE IN SEXUAL AROUSAL 1
102 DIVORCED 1
103 DRUG ABUSE 1
104 DRUG DEPENDENCE 1
105 DRUG EFFECT DECREASED 1
106 DRUG INTERACTION 1
107 DRUG WITHDRAWAL SYNDROME 1
108 DRY MOUTH 1
109 DYSARTHRIA 1
110 DYSLIPIDAEMIA 1
111 DYSPEPSIA 1
112 DYSPHAGIA 1
113 DYSPNOEA EXERTIONAL 1
114 DYSURIA 1
115 ECONOMIC PROBLEM 1
116 EMOTIONAL DISTRESS 1
117 EMPHYSEMA 1
118 ERYTHEMA 1
119 ESSENTIAL HYPERTENSION 1
120 EYE DISORDER 1
121 EYELID OEDEMA 1
122 FEELING HOT 1
123 FOOD INTERACTION 1
124 GAMBLING DISORDER 1
125 GASTRODUODENITIS HAEMORRHAGIC 1
126 GLUCOSE TOLERANCE IMPAIRED 1
127 HEADACHE 1
128 HEART VALVE INCOMPETENCE 1
129 HEPATIC CYST 1
130 HEPATIC ENZYME INCREASED 1
131 HEPATITIS 1
132 HEPATITIS CHOLESTATIC 1
133 HIP FRACTURE 1
134 HOMELESS 1
135 HOT FLUSH 1
136 HYPERCHOLESTEROLAEMIA 1
137 HYPERGLYCAEMIA 1
138 HYPERHIDROSIS 1
139 HYPERLIPIDAEMIA 1
140 HYPOAESTHESIA 1
141 HYPONATRAEMIA 1
142 IMPAIRED QUALITY OF LIFE 1
143 IMPULSE-CONTROL DISORDER 1
144 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
145 INCORRECT DOSE ADMINISTERED 1
146 INFECTION 1
147 INFLAMMATION 1
148 INFUSION RELATED REACTION 1
149 INJECTION SITE VESICLES 1
150 INJURY 1
151 INTERSTITIAL LUNG DISEASE 1
152 INTERVERTEBRAL DISC DISORDER 1
153 INTERVERTEBRAL DISC PROTRUSION 1
154 INTESTINAL OBSTRUCTION 1
155 JOINT SWELLING 1
156 LEFT ATRIAL DILATATION 1
157 LIBIDO DECREASED 1
158 MACULA THICKNESS MEASUREMENT 1
159 MAGNETIC RESONANCE IMAGING ABNORMAL 1
160 MALIGNANT NEOPLASM PROGRESSION 1
161 MEDICATION RESIDUE 1
162 MENTAL DISORDER 1
163 METASTASES TO ADRENALS 1
164 METASTASES TO BONE 1
165 METASTASES TO LIVER 1
166 METASTASES TO SPINE 1
167 MICTURITION URGENCY 1
168 MIGRAINE 1
169 MITRAL VALVE INCOMPETENCE 1
170 MUCOSAL INFLAMMATION 1
171 MUCOSAL ULCERATION 1
172 MULTIPLE INJURIES 1
173 MULTIPLE SCLEROSIS 1
174 MUSCLE SPASMS 1
175 MUSCULAR WEAKNESS 1
176 MUSCULOSKELETAL STIFFNESS 1
177 MYALGIA 1
178 MYOCARDIAL INFARCTION 1
179 MYOCARDIAL ISCHAEMIA 1
180 NEOPLASM PROGRESSION 1
181 NEPHROGENIC ANAEMIA 1
182 NEPHROLITHIASIS 1
183 NERVE ROOT COMPRESSION 1
184 NEUROPATHY PERIPHERAL 1
185 NEUTROPENIA 1
186 NO ADVERSE EVENT 1
187 OBESITY 1
188 OBSESSIVE-COMPULSIVE DISORDER 1
189 OCULAR DISCOMFORT 1
190 OCULAR HYPERAEMIA 1
191 OEDEMA 1
192 OPTIC ISCHAEMIC NEUROPATHY 1
193 ORTHOSTATIC HYPOTENSION 1
194 OSTEOARTHRITIS 1
195 OSTEONECROSIS 1
196 OSTEONECROSIS OF JAW 1
197 OVERGROWTH BACTERIAL 1
198 OXYGEN SATURATION DECREASED 1
199 PAIN IN JAW 1
200 PANCREATITIS 1
201 PANCREATITIS ACUTE 1
202 PARKINSON'S DISEASE 1
203 PARTNER STRESS 1
204 PATHOLOGICAL FRACTURE 1
205 PLEURAL FIBROSIS 1
206 PRODUCT ADHESION ISSUE 1
207 PRODUCT SUBSTITUTION ISSUE 1
208 PRODUCT TASTE ABNORMAL 1
209 PRODUCT USE IN UNAPPROVED INDICATION 1
210 PROSTATE CANCER 1
211 PSYCHOTIC DISORDER 1
212 PULMONARY MASS 1
213 RENAL IMPAIRMENT 1
214 RESPIRATORY TRACT INFECTION 1
215 RHINITIS ALLERGIC 1
216 RHINORRHOEA 1
217 SENSORY DISTURBANCE 1
218 SINUS CONGESTION 1
219 SINUSITIS 1
220 SNORING 1
221 SPINAL COLUMN STENOSIS 1
222 STAPHYLOCOCCAL ABSCESS 1
223 STAPHYLOCOCCAL INFECTION 1
224 STEVENS-JOHNSON SYNDROME 1
225 STRESS 1
226 SUICIDAL IDEATION 1
227 SUSPECTED COUNTERFEIT PRODUCT 1
228 SYNCOPE 1
229 TACHYCARDIA 1
230 TENDON INJURY 1
231 TENDONITIS 1
232 TESTICULAR PAIN 1
233 THERAPEUTIC PRODUCT EFFECT DECREASED 1
234 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
235 THERAPEUTIC RESPONSE DECREASED 1
236 THROAT IRRITATION 1
237 TOXIC EPIDERMAL NECROLYSIS 1
238 TRANSAMINASES INCREASED 1
239 TREMOR 1
240 TRICUSPID VALVE INCOMPETENCE 1
241 TYPE 2 DIABETES MELLITUS 1
242 TYPE V HYPERLIPIDAEMIA 1
243 URINARY HESITATION 1
244 URINARY TRACT INFECTION 1
245 URINE FLOW DECREASED 1
246 URTICARIA 1
247 VERTIGO 1
248 VIITH NERVE PARALYSIS 1
249 WEIGHT INCREASED 1
250 WHEEZING 1
251 WHITE BLOOD CELL COUNT DECREASED 1
252 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1